Sign up to save your podcasts
Or
Share Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?
Host: Matt Birnholz, MD
Guest: Hans Petter Eikesdal, MD
At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.
View all episodes
By ReachMDHost: Matt Birnholz, MD
Guest: Hans Petter Eikesdal, MD
At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.
More shows like Conference Coverage
View all
Medical Industry Feature
1 Listeners
SexMed
3 Listeners
Partners in Practice
3 Listeners
Second Opinion LIVE!
0 Listeners
Medical Breakthroughs from Penn Medicine
6 Listeners
Advances in Women's Health
14 Listeners
GI Insights
18 Listeners